Ibandronate
Ibandronate sodium tablet is a bisphosphonate indicated for the treatment and prevention of postmenopausal osteoporosis. ( 1.1 ). Limitations of Use The optimal duration of use has not been determined.
United States
$352
per month
India
$43
per month
You save
−88%save $309/mo · 88% cheaper
858.9K US scripts/yr$265M potential annual savings$302.1M US spend/yr
Drag to rotate · 3D structureC9H23NO7P2
SMILES: CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O
Compare the price
US price$352per month
India price$43per month
You save$30988% less
Based on 30 units per month. US $11.72 vs India $1.44 per unit.
Total over 1 periodSave $309$352 → $43
The bigger picture
Ibandronate is filled about 858.9K times a year under Medicare Part D. At the prices above, that works out to roughly:
Est. annual US spend
$302.1M
If sourced from India
$37.1M
Potential annual savings
$265M
−88%
Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.